Daniel J Campbell1, Joseph Chang2, Katarzyna Chawarska3. 1. Amgen Inc., Thousand Oaks, CA. 2. Yale University, New Haven. 3. Child Study Center, Yale University School of Medicine, New Haven, CT. Electronic address: Katarzyna.Chawarska@yale.edu.
Abstract
OBJECTIVE: Although early head and body overgrowth have been well documented in autism spectrum disorder (ASD), their prevalence and significance remain unclear. It is also unclear whether overgrowth affects males and females differentially, and whether it is associated with clinical outcomes later in life. METHOD: To evaluate prevalence of somatic overgrowth, gender effects, and associations with clinical outcomes, head circumference, height, and weight measurements were collected retrospectively between birth and 2 years of age in toddlers with ASD (n = 200) and typically developing (TD; n = 147) community controls. Symptom severity, verbal, and nonverbal functioning were assessed at 4 years. RESULTS: Abnormalities in somatic growth in infants with ASD were consistent with early generalized overgrowth (EGO). Boys but not girls with ASD were larger and exhibited an increased rate of extreme EGO compared to community controls (18.0% versus 3.4%). Presence of a larger body at birth and postnatal overgrowth were associated independently with poorer social, verbal, and nonverbal skills at 4 years. CONCLUSION: Although early growth abnormalities in ASD are less common than previously thought, their presence is predictive of lower social, verbal, and nonverbal skills at 4 years, suggesting that they may constitute a biomarker for identifying toddlers with ASD at risk for less-optimal outcomes. The results highlight that the search for mechanisms underlying atypical brain development in ASD should consider factors responsible for both neural and nonneural tissue development during prenatal and early postnatal periods, and can be informed by the finding that early overgrowth may be more readily observed in males than in females with ASD.
OBJECTIVE: Although early head and body overgrowth have been well documented in autism spectrum disorder (ASD), their prevalence and significance remain unclear. It is also unclear whether overgrowth affects males and females differentially, and whether it is associated with clinical outcomes later in life. METHOD: To evaluate prevalence of somatic overgrowth, gender effects, and associations with clinical outcomes, head circumference, height, and weight measurements were collected retrospectively between birth and 2 years of age in toddlers with ASD (n = 200) and typically developing (TD; n = 147) community controls. Symptom severity, verbal, and nonverbal functioning were assessed at 4 years. RESULTS: Abnormalities in somatic growth in infants with ASD were consistent with early generalized overgrowth (EGO). Boys but not girls with ASD were larger and exhibited an increased rate of extreme EGO compared to community controls (18.0% versus 3.4%). Presence of a larger body at birth and postnatal overgrowth were associated independently with poorer social, verbal, and nonverbal skills at 4 years. CONCLUSION: Although early growth abnormalities in ASD are less common than previously thought, their presence is predictive of lower social, verbal, and nonverbal skills at 4 years, suggesting that they may constitute a biomarker for identifying toddlers with ASD at risk for less-optimal outcomes. The results highlight that the search for mechanisms underlying atypical brain development in ASD should consider factors responsible for both neural and nonneural tissue development during prenatal and early postnatal periods, and can be informed by the finding that early overgrowth may be more readily observed in males than in females with ASD.
Authors: Neva M Corrigan; Dennis W W Shaw; Annette M Estes; Todd L Richards; Jeff Munson; Seth D Friedman; Geraldine Dawson; Alan A Artru; Stephen R Dager Journal: JAMA Psychiatry Date: 2013-09 Impact factor: 21.596
Authors: B F Sparks; S D Friedman; D W Shaw; E H Aylward; D Echelard; A A Artru; K R Maravilla; J N Giedd; J Munson; G Dawson; S R Dager Journal: Neurology Date: 2002-07-23 Impact factor: 9.910
Authors: Nanda N J Rommelse; Cindy T R Peters; Iris J Oosterling; Janne C Visser; Daniëlle Bons; Daphne J van Steijn; Jos Draaisma; Rutger-Jan van der Gaag; Jan K Buitelaar Journal: J Autism Dev Disord Date: 2011-01
Authors: Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler Journal: Nat Genet Date: 2011-05-15 Impact factor: 38.330
Authors: Guannan Li; Meng-Hsiang Chen; Gang Li; Di Wu; Chunfeng Lian; Quansen Sun; R Jarrett Rushmore; Li Wang Journal: J Autism Dev Disord Date: 2022-04-07
Authors: Mark D Shen; Christine W Nordahl; Deana D Li; Aaron Lee; Kathleen Angkustsiri; Robert W Emerson; Sally J Rogers; Sally Ozonoff; David G Amaral Journal: Lancet Psychiatry Date: 2018-09-27 Impact factor: 27.083
Authors: Sanam J Lalani; Tyler C Duffield; Haley G Trontel; Erin D Bigler; Tracy J Abildskov; Alyson Froehlich; Molly B D Prigge; Brittany G Travers; Jeffrey S Anderson; Brandon A Zielinski; Andrew Alexander; Nicholas Lange; Janet E Lainhart Journal: J Clin Exp Neuropsychol Date: 2017-10-26 Impact factor: 2.475